RxDoctor Payments Data

David Gay, MD

Ophthalmic Plastic and Reconstructive Surgery · Dripping Springs, TXNPI 1497054605

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $67,750 of the $92,875 with a category attached, or 72.9%. Amgen accounts for 97.5% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $26,049, more than ten times the $557 reported in 2019. Among ophthalmic plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,875in general payments, 2019–2025

Across 197 payments — averaging $471.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$91K
  • Johnson & Johnson Surgical Vision, Inc.$411
  • Biotissue Holdings Inc.$205
  • NEW World Medical,inc.$200
  • Heidelberg Engineering, Inc.$184
  • Tarsus Pharmaceuticals, Inc.$163
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$5,1005%
  • Speaking & faculty fees$67,75073%
  • Travel & lodging$13,46314%
  • Food & beverage$6,5457%
  • Education$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,875 in reported general payments places this provider in the 95th percentile of 36 ophthalmic plastic and reconstructive surgery providers in Texas.

See all ophthalmic plastic and reconstructive surgery providers in Texas

Medicare billing

Part B allowed, 2024
$317,067
Medicare patients
210
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base120$1,252
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha63$680
Prednisolone Acetate13$373
Tramadol Hcl87$172
Azithromycin11$57

Paid to pharmacies, not to this prescriber.

Other ophthalmic plastic and reconstructive surgery in Dripping Springs

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →